Silvan Vesenbeckh

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

Reassessment of the 2010–2011 Haiti cholera outbreak and rainfall-driven multiseason projections

Andrea Rinaldo, Enrico Bertuzzo, Lorenzo Mari et al. · Proceedings of the National Academy of Sciences · 2012 · 190 citations · Full text

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17

Cholera ante portas – The re-emergence of cholera in Kinshasa after a ten-year hiatus

Didier Bompangue, Silvan Vesenbeckh, Patrick Giraudoux et al. · PLoS Currents · 2012 · 36 citations · Full text

Veterinary Medicine, Infectious Diseases, Epidemiology +16

Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice

Rodolfo G. Goya, Paula C. Reggiani, Silvan Vesenbeckh et al. · American Journal of Physiology-Endocrinology and Metabolism · 2007 · 33 citations · Full text

Life Sciences, Endocrinology, Physiology +17

Minimal inhibitory concentrations of first-line drugs of multidrug -resistant tuberculosis isolates

Nicolas Schönfeld, Thorsten Bergmann, Silvan Vesenbeckh et al. · Lung India · 2012 · 24 citations · Full text

Pharmacy, Pharmacology, Antimicrobial Pharmacotherapy +13